ReDisulphID

a tool for identifying drug-targetable redox-active disulphides

Thymic stromal lymphopoietin

Intramolecular
Cysteine 34 and cysteine 110
Cysteine 90 and cysteine 137
Cysteine 69 and cysteine 75
A redox-regulated disulphide may form within Thymic stromal lymphopoietin between cysteines 34 and 110.

Details

Redox score ?
89
PDB code
5j13
Structure name
structural basis for tslp antagonism by the therapeutic antibody tezepelumab (medi9929 / amg-157)
Structure deposition date
2016-03-28
Thiol separation (Å)
2
Half-sphere exposure sum ?
52
Minimum pKa ?
nan
% buried
nan
Peptide accession
Q969D9
Residue number A
34
Residue number B
110
Peptide name
Thymic stromal lymphopoietin

Ligandability

Cysteine 34 of Thymic stromal lymphopoietin

Cysteine 110 of Thymic stromal lymphopoietin

A redox-regulated disulphide may form within Thymic stromal lymphopoietin between cysteines 90 and 137.

Details

Redox score ?
88
PDB code
5j13
Structure name
structural basis for tslp antagonism by the therapeutic antibody tezepelumab (medi9929 / amg-157)
Structure deposition date
2016-03-28
Thiol separation (Å)
2
Half-sphere exposure sum ?
45
Minimum pKa ?
nan
% buried
nan
Peptide accession
Q969D9
Residue number A
90
Residue number B
137
Peptide name
Thymic stromal lymphopoietin

Ligandability

Cysteine 90 of Thymic stromal lymphopoietin

Cysteine 137 of Thymic stromal lymphopoietin

A redox-regulated disulphide may form within Thymic stromal lymphopoietin between cysteines 69 and 75.

Details

Redox score ?
82
PDB code
5j13
Structure name
structural basis for tslp antagonism by the therapeutic antibody tezepelumab (medi9929 / amg-157)
Structure deposition date
2016-03-28
Thiol separation (Å)
2
Half-sphere exposure sum ?
78
Minimum pKa ?
nan
% buried
nan
Peptide accession
Q969D9
Residue number A
69
Residue number B
75
Peptide name
Thymic stromal lymphopoietin

Ligandability

Cysteine 69 of Thymic stromal lymphopoietin

Cysteine 75 of Thymic stromal lymphopoietin

If this tool was useful for finding a disulphide, please cite: